tiprankstipranks
Evaxion Biotech (EVAX)
NASDAQ:EVAX
US Market
Holding EVAX?
Track your performance easily

Evaxion Biotech (EVAX) Income Statement

211 Followers

Evaxion Biotech Income Statement

Last quarter (Q4 2023), Evaxion Biotech's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Evaxion Biotech's net income was $―. See Evaxion Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
-$ 73.00K$ -2.35M-$ -15.02M$ 0.00
Cost of Revenue
------
Gross Profit
-$ 73.00K$ -2.35M-$ -15.02M-
Operating Expense
$ 12.34M$ 22.27M$ 52.04M$ 52.58M$ 33.14M$ 10.86M
Operating Income
$ -12.34M$ -22.20M$ -54.38M$ -52.58M$ -33.14M$ -10.86M
Net Non Operating Interest Income Expense
$ 1.48M$ -743.00K$ 2.83M$ 2.04M$ -14.80M$ -1.21M
Other Income Expense
-$ -282.00K$ 23.17M$ 24.61M$ -171.00K$ 56.00K
Pretax Income
$ -10.86M$ -22.91M$ -23.94M$ -24.71M$ -47.77M$ -12.02M
Tax Provision
$ -352.00K$ -790.00K$ -772.00K$ -178.00K$ -1.56M$ -825.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -10.51M$ -22.13M$ -73.95M$ -74.99M$ -46.21M$ -11.20M
Basic EPS
$ -0.44$ -0.81$ -0.98$ -1.26$ -0.97$ -0.58
Diluted EPS
$ -0.44$ -0.81$ -0.98$ -1.12$ -0.97$ -0.58
Basic Average Shares
$ 47.67M$ 27.34M$ 23.64M$ 59.51M$ 15.43M$ 19.20M
Diluted Average Shares
$ 47.67M$ 27.34M$ 75.46M$ 66.95M$ 15.43M$ 19.20M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 12.34M$ 22.27M$ 52.04M$ 52.58M$ 33.14M$ 10.86M
Net Income From Continuing And Discontinued Operation
$ -10.51M$ -22.13M$ -73.95M$ -74.99M$ -46.21M$ -11.20M
Normalized Income
$ -10.51M----$ -11.25M
Interest Expense
$ 760.00K----$ 1.22M
EBIT
$ -10.10M-$ -23.98M$ -24.71M$ -47.77M$ -10.80M
EBITDA
$ -10.10M-$ -23.98M$ -24.71M$ -47.77M$ -10.72M
Currency in USD

Evaxion Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis